Developing a Blended diet guideline Developing Blended Diet Guideline

This webinar, hosted by Dr. Helen Evans-Howells, focuses on recognising and managing cow’s milk protein allergy (CMPA) in primary care. It offers an overview of how to effectively work with patients who have CMPA in a community setting. Key learning points include the differences between allergies and intolerances, when to test for allergies and how to interpret results, and insights into the future of food allergies. The session concludes with an informative Q&A session.

Kathyrn Simpson, Paediatric Dietitian, worked with 8 of her families for the acceptability and tolerance study for Peptamen Junior 1.5. Hear about Kathryn’s experience of being involved in the trial and in particular, learn about two children who took part. Case study 1 focuses on a 6 year old girl with complex TOF and OA. Case study 2 is an 8 year old girl with Cockayne Syndrome.  

A great option to up protein levels on a pasta dish, this Bolognese sauce recipe is suitable for IDDSI level 5 dysphagia patients.

Objective: EAT-10 helps to measure swallowing difficulties. It may be important for you to talk with your physician about treatment options for symptoms.

Join specialist dietitians from the Royal Marsden Hospital, who will discuss a case study on the management of enteral nutrition for a patient with neuroendocrine tumour of the pancreas.

Karen Green is well known in dietetics for her contribution to the Manual of Dietetic Practice and BDA Best Practice Guidelines on Parkinson’s disease. In this lecture, she explores the impact of Parkinson’s disease on the gut, including the management of gastroparesis, constipation and small intestinal bacterial overgrowth.

In 2023, Nestlé Health Science conducted a survey of UK healthcare professionals with the aim of understanding more about gastrointestinal symptoms during cancer treatment. View our short animation for the survey highlights, or for more detail we’ve created a downloadable infographic below.

Learn more about MCTs and their role in reducing fat malabsorption

WHAT MAKES AN EFFECTIVE SPECIALIST CMA FORMULA? Very few eHFs and AAFs have been shown effective, both in terms of allergy and growth.6,7 At Nestlé Health Science, we set the highest standards for our CMA formulas, SMA® Althéra® and SMA® Alfamino®, ensuring both manufacturing excellence and robust clinical evidence to demonstrate: Proven hypoallergenicity  According to guidelines, the gold standard is for hypoallergenic formulas to be tolerated by at least 90% of infants with proven CMA (with 95% confidence interval) in a clinical trial.1,3,6  Growth and development  According to guidelines, the gold standard is for hypoallergenic formulas to demonstrate normal growth in a clinical trial, because whilst eHF and AAF nutritional profiles are governed by strict regulations,7,8 there are still significant compositional differences between brands.5 REFERENCES: 1. Luyt D et al. Clin Exp Allergy 2014; 44: 642–672. 2. Grimshaw K et al. Clin Transl Allergy 2016; 6: 1. 3. Koletzko S et al. JPGN 2012; 55(2): 221–229. 4. Muraro A et al. Allergy 2014; 69(5): 590–601. 5. Meyer R et al. EMJ Allergy and Immunol. 2017; 2(1): 46–51. 6. Chauveau, A. et al. Pediatr Allergy Immunol. 2016; 27(5): 541–543.   7. Commission Delegated regulation (EU) 2016/128. 8. Commission directive 1999/21/EC

The aim of this webinar is to aid primary care individuals in the diagnosis and management of cows' milk protein allergy. Evidence suggests that it can take an average of 10 weeks and 4 visits to a healthcare professional to get a diagnosis of cows' milk allergy (CMA).1

Kate discusses how adding flavours isn’t recommended - she further discusses how formulas containing lactose can taste better and therefore may be tolerated better.